First Washington CORP Purchases New Stake in OraSure Technologies, Inc. (OSUR)

First Washington CORP bought a new stake in shares of OraSure Technologies, Inc. (NASDAQ:OSUR) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 254,300 shares of the medical instruments supplier’s stock, valued at approximately $4,796,000. OraSure Technologies makes up about 2.3% of First Washington CORP’s investment portfolio, making the stock its 12th biggest position. First Washington CORP owned approximately 0.42% of OraSure Technologies as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of OSUR. Vanguard Group Inc. increased its holdings in shares of OraSure Technologies by 19.8% during the 2nd quarter. Vanguard Group Inc. now owns 5,352,832 shares of the medical instruments supplier’s stock valued at $92,390,000 after purchasing an additional 886,333 shares in the last quarter. Emerald Advisers Inc. PA purchased a new position in shares of OraSure Technologies during the 4th quarter valued at approximately $12,518,000. Fuller & Thaler Asset Management Inc. increased its holdings in shares of OraSure Technologies by 175.6% during the 3rd quarter. Fuller & Thaler Asset Management Inc. now owns 898,397 shares of the medical instruments supplier’s stock valued at $20,214,000 after purchasing an additional 572,397 shares in the last quarter. Robeco Institutional Asset Management B.V. increased its holdings in shares of OraSure Technologies by 2,181.8% during the 3rd quarter. Robeco Institutional Asset Management B.V. now owns 434,550 shares of the medical instruments supplier’s stock valued at $9,778,000 after purchasing an additional 415,506 shares in the last quarter. Finally, SG Capital Management LLC purchased a new position in shares of OraSure Technologies during the 3rd quarter valued at approximately $9,205,000. 91.62% of the stock is owned by hedge funds and other institutional investors.

OraSure Technologies, Inc. (OSUR) opened at $18.00 on Monday. The firm has a market cap of $1,091.67, a PE ratio of 35.29, a PEG ratio of 4.60 and a beta of 1.43. OraSure Technologies, Inc. has a 1 year low of $10.28 and a 1 year high of $23.01.

OraSure Technologies (NASDAQ:OSUR) last posted its earnings results on Wednesday, February 7th. The medical instruments supplier reported $0.12 EPS for the quarter, beating the Zacks’ consensus estimate of $0.11 by $0.01. OraSure Technologies had a net margin of 18.52% and a return on equity of 13.09%. The company had revenue of $52.00 million for the quarter, compared to analysts’ expectations of $50.20 million. During the same quarter in the prior year, the company posted $0.13 earnings per share. OraSure Technologies’s revenue for the quarter was up 46.5% compared to the same quarter last year. research analysts anticipate that OraSure Technologies, Inc. will post 0.31 earnings per share for the current year.

Several equities analysts have recently weighed in on the stock. Zacks Investment Research raised shares of OraSure Technologies from a “sell” rating to a “hold” rating in a report on Tuesday, January 9th. ValuEngine lowered shares of OraSure Technologies from a “buy” rating to a “hold” rating in a report on Thursday, November 2nd. BidaskClub raised shares of OraSure Technologies from a “buy” rating to a “strong-buy” rating in a report on Saturday, January 20th. Jefferies Group lowered shares of OraSure Technologies from a “buy” rating to a “hold” rating in a report on Thursday, November 2nd. Finally, Canaccord Genuity reissued a “buy” rating and issued a $24.00 price target on shares of OraSure Technologies in a report on Friday, February 2nd. Two equities research analysts have rated the stock with a hold rating, three have given a buy rating and one has assigned a strong buy rating to the company’s stock. OraSure Technologies presently has an average rating of “Buy” and an average target price of $22.25.

WARNING: This news story was published by The Lincolnian Online and is the sole property of of The Lincolnian Online. If you are accessing this news story on another site, it was stolen and reposted in violation of U.S. & international copyright laws. The correct version of this news story can be read at https://www.thelincolnianonline.com/2018/02/12/first-washington-corp-purchases-new-stake-in-orasure-technologies-inc-osur.html.

OraSure Technologies Company Profile

OraSure Technologies, Inc (OraSure) is involved in the development, manufacture, marketing and sale of oral fluid diagnostic products and specimen collection devices using its technologies, as well as other diagnostic products, including immunoassays and other in vitro diagnostic tests that are used on other specimen types.

Want to see what other hedge funds are holding OSUR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for OraSure Technologies, Inc. (NASDAQ:OSUR).

Institutional Ownership by Quarter for OraSure Technologies (NASDAQ:OSUR)

Receive News & Ratings for OraSure Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OraSure Technologies and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply